[Infographics] Two patients with dyslipidaemia treated with oral bempedoic acid + ezetimibe FDC

10 Oct 2025
Dr. Walter Wai-Chee Chen
Dr. Walter Wai-Chee ChenSpecialist in Cardiology; Private practice; Hong Kong
Dr. Walter Wai-Chee Chen
Dr. Walter Wai-Chee Chen Specialist in Cardiology; Private practice; Hong Kong
[Infographics] Two patients with dyslipidaemia treated with oral bempedoic acid + ezetimibe FDC
Dr Walter Wai-Chee Chan's (Specialist in Cardiology in Hong Kong) cases: one patient with statin-induced autoimmune myositis, and another patient with uncontrolled LDL-C despite maximally tolerated statin + ezetimibe. Find out how these patients responded to and tolerated oral bempedoic acid + ezetimibe fixed-dose combination (FDC) treatment. 
The featured infographic is supported by Daiichi Sankyo. 
HK-DAI-NN-2509009 Approval Date: Oct 2025

Related MIMS Drugs

Resources

[Infographics] Two patients with dyslipidaemia treated with oral bempedoic acid + ezetimibe FDC

[Infographics] Two patients with dyslipidaemia treated with oral bempedoic acid + ezetimibe FDC

[Infographics] Two patients with dyslipidaemia treated with oral bempedoic acid + ezetimibe FDC

[Infographics] Two patients with dyslipidaemia treated with oral bempedoic acid + ezetimibe FDC